health inequalities | pharmaphorum

Friday 20 March 2026

health inequalities

Market Access

Health technology in assessment

NICE’s health inequalities modular update: Commentary on NIC...

NICE’s modular update on health inequalities, consulted on in January and finalised in May, has now been incorporated into its manual.1 A total of 26 individuals and organi

Market Access

positive step

NICE’s health inequalities modular update: A positive step, ...

The start of a new year saw the launch of a consultation on NICE’s eagerly anticipated health inequalities modular update to the manual for health technology evaluation.1

Patients

Putting patients at the centre of innovation

Putting patients at the centre of innovation starts with cli...

A reliable and sustainable clinical trial system plays a pivotal role in supporting patients with unmet needs.

Oncology

quality of life

How quality of life can drive equitable cancer care and outc...

Health inequalities are increasingly evident and affect more people than ever.

Oncology

oncology is a complex healthcare area

Sponsored

Oncology in the NHS: Situations, challenges, and solutions

Oncology is a singularly complex healthcare area.

Patients

health inequalities

Using co-creation to tackle health inequalities through tran...

Vani Manja is the country MD and head of human pharma at Boehringer Ingelheim UK & Ireland.